HTG Molecular Diagnostics Expands Its IVD Agreement With Illumina to Increase the Number of Test Kits
TUCSON, Ariz., June 05, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has amended and restated its IVD Test Development and …